ArticleOncotarget2017

Correction: Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences.

Vincenzo Quagliariello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.